5-hydroxydecanoate has been researched along with Arterial Obstructive Diseases in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hide, EJ | 1 |
| Piper, J | 1 |
| Thiemermann, C | 1 |
1 other study available for 5-hydroxydecanoate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arterial Occlusive Diseases; Blood Pressure | 1995 |